BWV - Blue Water Vaccines GAAP EPS of -$0.27 November, 10 2022 09:22 AM Blue Water Vaccines Inc. Blue Water Vaccines press release ( NASDAQ: BWV ): Q3 GAAP EPS of -$0.27. Cash was $29.1 million as of September 30, 2022, as compared to $1.9 million as of December 31, 2021. For further details see: Blue Water Vaccines GAAP EPS of -$0.27